L63.1
Alopecia universalis
Clinical Classification Guidelines
Medical Intelligence & Overview
Alopecia universalis is an uncommon autoimmune disorder characterized by the complete loss of hair across the entire scalp and body. As the most advanced form of alopecia areata, it results in total hair loss in areas where hair normally grows, including eyebrows, eyelashes, and other body hair. While it can develop suddenly or gradually, it often appears in individuals in their teens or early adulthood. Despite its dramatic appearance, alopecia universalis is primarily a cosmetic concern, but it may also have emotional and psychological impacts on those affected.
Causes & Symptoms
Clinical Causes: Autoimmune response: The body's immune system mistakenly attacks hair follicles, leading to hair loss. Genetic predisposition: A family history of autoimmune disorders or alopecia areata increases susceptibility. Environmental factors: Stress, infections, or environmental triggers may contribute, though their roles are less clear. Other autoimmune conditions: Presence of conditions like thyroid disease or vitiligo can be associated. Certain medications or treatments: Rarely, drugs that modulate immune response may be linked to hair loss.
Key Symptoms: Rapid or gradual hair loss across the scalp and entire body. Smooth, hairless skin where hair has fallen out. Possible presence of small, black dots representing broken hair stubs. Itching or discomfort is generally absent. Psychological distress caused by appearance changes. In some cases, changes in skin pigmentation or texture may be observed.
Diagnostic & Treatment
Diagnosis Path: Diagnosis primarily involves a physical examination, noting the pattern and extent of hair loss. A healthcare professional may perform a scalp biopsy to confirm the autoimmune nature by examining hair follicle tissue. Blood tests can help rule out other underlying conditions, such as thyroid issues or infections. Trichoscopy, a special microscope for hair and scalp, may assist in diagnosis by revealing characteristic hair shaft features. The absence of other associated autoimmune symptoms and the pattern of non-scarring hair loss support the diagnosis of alopecia universalis.
Treatment Protocols: Immunotherapy: Topical or injectable agents designed to modify immune response, such as contact or topical sensitizers. Corticosteroids: Topical, intralesional, or systemic steroids may reduce inflammation and suppress immune activity. Minoxidil: Over-the-counter medication that can promote hair growth in some cases. Janus kinase (JAK) inhibitors: A newer class of drugs showing promise in stimulating hair regrowth, currently under clinical investigation. Phototherapy: Light-based treatments like ultraviolet therapy to stimulate hair follicles. Psychological support and counseling: To address emotional impacts and improve quality of life. Lifestyle modifications: Managing stress and maintaining overall health may have supportive benefits.
Clinical Advice & FAQs
Billing Guidance
Is L63.1 a billable ICD-10 code?
Yes, L63.1 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report L63.1?
Clinical documentation must specify the nature of Alopecia universalis and any associated comorbidities for accurate reporting.
Cite this Clinical Reference